Pasar al contenido principal

PROTEOMICA POSTTRADUCCIONAL: APLICACIONES EN INVESTIGACION CARDIOVASCULAR

PGC2018-097019-B-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de Generación de Conocimiento y Fortalecimiento Científico y Tecnológico del Sistema de I+D+i
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D (Excelencia / Generación de Conocimiento)
Año convocatoria 2018
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CARLOS III (F.S.P.)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 24
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Complement C5 protein as a marker of subclinical atherosclerosis

  • Martínez-López, Diego
  • Roldan-Montero, Raquel
  • García-Marqués, Fernando
  • Núñez, Estefanía
  • Jorge, Inmaculada
  • Camafeita, Emilio
  • Mínguez, Pablo
  • Rodríguez de Córdoba, Santiago
  • López-Melgar, Beatriz
  • Lara-Pezzi, Enrique
  • Fernández-Ortíz, Antonio
  • Ibáñez, Borja
  • Valdivielso, Jose Manuel
  • Fuster, Valentín
  • Michel, Jean-Baptiste
  • Blanco-Colio, Luis Miguel
  • Vázquez, Jesús
  • Martín-Ventura, Jose Luis
16 p.-5 fig.-3 tab.-1 il. cent., BACKGROUND: The mechanisms underlying early atherosclerotic plaque formation are not completely understood. Moreover, plasma biomarkers of subclinical atherosclerosis are lacking., OBJECTIVES: The purpose of this study was to analyze the temporal and topologically resolved protein changes taking place in human aortas with early atherosclerosis to find new potential diagnostic and/or therapeutic targets., METHODS: The protein composition of healthy aortas (media layer) or with early atheroma (fatty streak and fibrolipidic, media and intima layers) was analyzed by deep quantitative multiplexed proteomics. Further analysis was performed by Western blot, immunohistochemistry, real-time polymerase chain reaction, and enzyme-linked immunosorbent assay. Plasma levels of complement C5 were analyzed in relation to the presence of generalized (>2 plaques) or incipient (0 to 2 plaques) subclinical atherosclerosis in 2 independent clinical cohorts (PESA [Progression of Early Subclinical Atherosclerosis] [n=360] and NEFRONA [National Observatory of Atherosclerosis in Nephrology] [n=394])., RESULTS: Proteins involved in lipid transport, complement system, immunoglobulin superfamily, and hemostasis are increased in early plaques. Components from the complement activation pathway were predominantly increased in the intima of fibrolipidic plaques. Among them, increased C5 protein levels were further confirmed by Western blot, enzyme-linked immunosorbent assay and immunohistochemistry, and associated with in situ complement activation. Plasma C5 was significantly increased in individuals with generalized subclinical atherosclerosis in both PESA and NEFRONA cohorts, independently of risk factors. Moreover, in the PESA study, C5 plasma levels positively correlated with global plaque volume and coronary calcification., CONCLUSIONS: Activation of the complement system is a major alteration in early atherosclerotic plaques and is reflected by increased C5 plasma levels, which have promising value as a novel circulating biomarker of subclinicalatherosclerosis., This study was funded by the Spanish MINECO(SAF2016-80843-R, BIO2015-67580-P, and PGC2018-097019-B-I00), CAM (Complemento II-CM, S2017/BMD-3673),Fondo de Investigaciones Sanitarias ISCiii-FEDER (Biobancos RD09/0076/00101) and PRB3 (IPT17/0019, ProteoRed), and FEDER “Una manera de hacer Europa.” CIBERCV is an Instituto de Salud Carlos III project. The work leading to these results has also received funding from “la Caixa” Banking Foundation under the project code HR17-00247. The PESA study is cofunded equally by the Centro Nacional de Investigaciones Cardiovasculares (CNIC), and Banco Santander, Madrid, Spain. The study also receives funding from the Instituto de Salud Carlos III (PI15/02019) and the European Regional Development Fund (ERDF) “Una manera de hacer Europa.”, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Improved integrative analysis of the thiol redox proteome using filter-aided sample preparation

  • Bonzón-Kulichenko, Elena
  • Camafeita, Emilio
  • López, Juan A.
  • Gómez-Serrano, María
  • Jorge, Inmaculada
  • Calvo, Enrique
  • Núñez, Estefanía
  • Trevisan-Herraz, Marco
  • Bagwan, Navratan
  • Bárcena, José Antonio
  • Peral, Belén
  • Vázquez, Jesús
Changes in the oxidation state of protein Cys residues are involved in cell signalling and play a key role in a variety of pathophysiological states. We had previously developed GELSILOX, an in-gel method that enables the large-scale, parallel analysis of dynamic alterations to the redox state of Cys sites and protein abundance changes. Here we present FASILOX, a further development of the GELSILOX approach featuring: i) significantly increased peptide recovery, ii) enhanced sensitivity for the detection of Cys oxidative alterations, and iii) streamlined workflow that results in shortened assay duration. In mitochondria isolated from the adipose tissue of obese, diabetic patients, FASILOX revealed a sexually dimorphic trait of Cys oxidation involving mainly mitochondrial oxidative phosphorylation complexes. These results provide the first evidence for a decreased efficiency in the antioxidant response of men as compared to women., This study was supported by competitive grants from the Spanish Ministry of Science, Innovation and Universities (BIO2015-67580-P, PGC2018-097019-B-I00 and RTI2018-093864-B-100), the Ministry of Economy, Industry and Competitiveness (BFU2016-80006-P) through the Carlos III Institute of Health-Fondo de Investigación Sanitaria grant PRB3 (IPT17/0019 - ISCIII-SGEFI / ERDF, ProteoRed), the Fundació MaratóTV3 (grant 122/C/2015) and “la Caixa” Banking Foundation (project code HR17-00247). The CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the Ministerio de Ciencia, Innovación y Universidades (MCNU) and the Pro CNIC Foundation, and is a Severo Ochoa Center of Excellence (SEV-2015-0505)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Intracellular calcium mishandling leads to cardiac dysfunction and ventricular arrhythmias in a mouse model of propionic acidemia

  • Tamayo, María
  • Fulgencio-Covián, A.
  • Navarro-García, Jose A.
  • Val-Blasco, Almudena
  • Ruiz-Hurtado, Gema
  • Gil-Fernández, Marta
  • Martín-Nunes, Laura
  • Lopez, J. A.
  • Desviat, Lourdes R.
  • Delgado, Carmen
  • Richard, C.
  • Fernández-Velasco, María
Propionic acidemia (PA) is a rare metabolic disease associated with mutations in genes encoding the α and β subunits of the enzyme propionyl-CoA carboxylase. The accumulation of toxic metabolites results in mitochondrial dysfunction, increased reactive oxygen species production and oxidative damage, which have been associated with the disease pathophysiology. Clinical symptoms are heterogeneous and include cardiac complications, mainly cardiac dysfunction and arrhythmias, which are recognized as one of the major life-threatening manifestations in patients. We aimed to investigate the molecular mechanisms underlying the cardiac phenotype using a hypomorphic mouse model (Pcca−/−(A138T)) that recapitulates some biochemical and clinical characteristics of PA. We demonstrate that Pcca−/−(A138T) mice present with depressed cardiac function along with impaired cell contractility when compared to the wild-type mice. Cardiac dysfunction in Pcca−/−(A138T) mice was associated with lower systolic Ca2+ release ([Ca2+]i transients), impairment in the sarcoplasmic reticulum (SR) Ca2+ load and decreased Ca2+ re-uptake by SR-Ca2+ ATPase (SERCA2a). These functional changes correlated well with the depressed activity of SERCA2a, the elevated ROS levels and SERCA2a oxidation rate in cardiomyocytes isolated from Pcca−/−(A138T) mice. In addition, decreased SR-Ca2+ load in Pcca−/−(A138T) cardiomyocytes was associated with increased diastolic Ca2+ release. The increase in Ca2+ sparks, Ca2+ waves and spontaneous [Ca2+]i transients in Pcca−/−(A138T) cardiomyocytes could be responsible for the induction of ventricular arrhythmias detected in these mice. Overall, our results uncover the role of impaired Ca2+ handling in arrhythmias and cardiac dysfunction in PA, and identify new targets for the development of therapeutic approaches for this devastating metabolic disease., This work was supported by Spanish Ministry of Economy and Competitiveness and European Regional Development Fund (SAF2016-76004-R, SAF2017-84777-R and PGC2018-097019-B-I00), Instituto de Salud Carlos III (ISCIII) (PI17/01093, PI17/01344 and IPT17/0019 - ISCIII-SGEFI/ERDF, ProteoRed), European Regional Development Fund (FEDER), FSE, the Fundació Marató TV3 (grant 122/C/2015) and CIBERER and CIBER-CV, networks funded by ISCIII. Centro de Biología Molecular Severo Ochoa receives an institutional grant from Fundación Ramón Areces. The CNIC is supported by ISCIII, Spanish Ministry of Science, Innovation and Universities (MCIU) and the Pro CNIC Foundation, and is a Severo Ochoa Center of Excellence (SEV-2015-0505). MF-V is Miguel Servet II researcher of ISCIII (MSII16/00047 Carlos III Health Institute). GR-H is Miguel Servet I researcher of ISCIII (CP15/00129 Carlos III Health Institute). MT is a PhD student funded by the FPU program of MCIU (FPU17/06135). AFC is a PhD student funded by the FPI-UAM program., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A Network of Macrophages Supports Mitochondrial Homeostasis in the Heart

  • Nicolás-Ávila, José A.
  • Lechuga, Ana
  • Sanchez-Díaz, María
  • Díaz-García, Elena
  • Santiago, Demetrio J.
  • Rubio-Ponce, Andrea
  • LiangYao Li, Jackson
  • Balachander, Akhila
  • Quintana, Juan A.
  • Martínez de Mena, Raquel
  • Castejón-Vega, Beatriz
  • Pun-García, Andrés
  • Través, Paqui G.
  • Bonzón-Kulichenko, Elena
  • García-Marqués, Fernando
  • Cussó, Lorena
  • González, Noelia A.
  • González-Guerra, Andrés
  • Roche-Molina, Marta
  • Martin-Salamanca, Sandra
  • Crainiciuc, Georgiana
  • Guzmán, Gabriela
  • Larrazabal, Jagoba
  • Herrero-Galán, Elías
  • Alegre-Cebollada, Jorge
  • Lemke, Greg
  • Rothlin, Carla V.
  • Jiménez-Borreguero, Luis J.
  • Reyes, Guillermo
  • Castrillo, Antonio
  • Desco, Manuel
  • Muñoz-Cánoves, Pura
  • Ibáñez, Borja
  • Torres, Miguel
  • Guan Ng, Lai
  • Priori, Silvia G.
  • Bueno, Héctor
  • Vázquez, Jesús
  • Cordero, Mario D.
  • Bernal, Juan
  • Enríquez, José Antonio
  • Hidalgo, Andrés
Cardiomyocytes are subjected to the intense mechanical stress and metabolic demands of the beating heart. It is unclear whether these cells, which are long-lived and rarely renew, manage to preserve homeostasis on their own. While analyzing macrophages lodged within the healthy myocardium, we discovered that they actively took up material, including mitochondria, derived from cardiomyocytes. Cardiomyocytes ejected dysfunctional mitochondria and other cargo in dedicated membranous particles reminiscent of neural exophers, through a process driven by the cardiomyocyte's autophagy machinery that was enhanced during cardiac stress. Depletion of cardiac macrophages or deficiency in the phagocytic receptor Mertk resulted in defective elimination of mitochondria from the myocardial tissue, activation of the inflammasome, impaired autophagy, accumulation of anomalous mitochondria in cardiomyocytes, metabolic alterations, and ventricular dysfunction. Thus, we identify an immune-parenchymal pair in the murine heart that enables transfer of unfit material to preserve metabolic stability and organ function. Video Abstract: [Figure presented] A system of macrophages in the heart supports cardiomyocyte health by phagocytosing exopher particles ejected from cardiomyocytes that contain defective mitochondria, among other cellular contents., This study was supported by Intramural grants from the Severo Ochoa program (IGP-SO); grants SAF2015-71878-REDT and SAF2014-56819-R from the Ministerio de Ciencia e Innovacion (MICINN) to A.C.; European Research Council grant EU-rhythmy (ERC-ADG-2014-ID:669387) to S.G.P., and MATRIX (ERC-COG-2018-ID: 819775) to B.I.; L.G.N. is supported by SIgN core funding from A∗STAR; grant BFU2016-75144-R from the Ministry of Science and Innovation to J.A.B,; grants PGC2018-096486-B-I00 and RD16/0011/0019 (ISCIII) from MICINN, TNE-17CVD04 from the Leducq Foundation, and S2017/BMD-3875 from the Comunidad de Madrid to M.T; intramural grant TPC/O-SO and grants SAF2015-65633-R, RTI2018-099357-B-I00, and HFSP (RGP0016/2018) to J.A.E.; intramural grant IGP-SO to J.A.-C. and A.H.; BIO2017-83640-P and RYC-2014-16604 to J.A-C; grants PRB3 (IPT17/0019-ISCIII-SGEFI/ERDF, ProteoRed) from the Carlos III Institute of Health and Fondo de Investigaciones Sanitarias, BIO2015-67580-P and PGC2018-097019-B-I00 from MICINN to J.V.; RTI2018-096068 from MICINN, AFM, MDA, LaCaixa-HR17-00040, UPGRADE-H2020-825825, and European Research Council (ERC-741538) to P.M.C.; S2017/BMD-3867 RENIM-CM from the Comunidad de Madrid and cofunded with European structural and investment funds to M.D.; 120/C/2015-20153032 from Fundació la Marató de TV3, SAF2015-65607-R and RTI2018-095497-B-I00 from MICINN, HR17_00527 from La Caixa Foundation, and TNE-18CVD04 from the Leducq Foundation to A.H.; C.V.R. is a Howard Hughes Medical Institute Faculty Scholar; J.A.N-A is supported by fellowship SVP-2014-068595, A.V.L.-V. by SVP-2013-068089, L.E.-M. by FJCI-2016-29384, and A.R.-P. by BES-2016-076635, all from MICINN; and the CNIC International Postdoctoral Program (EU grant agreement 600396 to D.J.S.). The CNIC is supported by the MICINN and the Pro-CNIC Foundation and is a Severo Ochoa Center of Excellence (MICINN award SEV-2015-0505).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The chaperonin CCT controls T cell receptor–driven 3D configuration of centrioles

  • Martín-Cófreces, Noa Beatriz
  • Chichón, Francisco Javier
  • Calvo, E.
  • Torralba, D.
  • Bustos-Moran, E.
  • Dosil, S. G.
  • Rojas-Gómez, Amelia
  • Bonzón-Kulichenko, Elena
  • Lopez, J. A.
  • Otón, Joaquín
  • Sorrentino, A.
  • Zabala, Juan Carlos
  • Vernos, I.
  • Vázquez, J.
  • Valpuesta, José M.
  • Sánchez-Madrid, Francisco
© 2020 The Authors., T lymphocyte activation requires the formation of immune synapses (IS) with antigen-presenting cells. The dynamics of membrane receptors, signaling scaffolds, microfilaments, and microtubules at the IS determine the potency of T cell activation and subsequent immune response. Here, we show that the cytosolic chaperonin CCT (chaperonin-containing TCP1) controls the changes in reciprocal orientation of the centrioles and polarization of the tubulin dynamics induced by T cell receptor in T lymphocytes forming an IS. CCT also controls the mitochondrial ultrastructure and the metabolic status of T cells, regulating the de novo synthesis of tubulin as well as posttranslational modifications (poly-glutamylation, acetylation, Δ1 and Δ2) of αβ-tubulin heterodimers, fine-tuning tubulin dynamics. These changes ultimately determine the function and organization of the centrioles, as shown by three-dimensional reconstruction of resting and stimulated primary T cells using cryo-soft x-ray tomography. Through this mechanism, CCT governs T cell activation and polarity., Cryo-SXT work was supported by ALBA Synchrotron standard proposals 2015021148 and 2016021638 to F.J.C., N.B.M.-C., and J.M.V. This study was supported by grants SAF2017-82886-R (to F.S.-M.), PID2019-105872GB I00/AEI/10.13039/501100011033 (AEI/FEDER, UE), BFU2016-75984 (to J.M.V.), and BIO2015-67580-P and PGC2018-097019-B-I00 (to J.V.) from the Spanish Ministry of Economy and Competitiveness (MINECO), grants INFLAMUNE-S2017/BMD-23671 (to F.S.-M.) and P2018/NMT-4389 (to J.M.V.) from the Comunidad de Madrid, ERC-2011-AdG 294340-GENTRIS (to F.S.-M.), a 2019 grant from the Ramón Areces Foundation “Ciencias de la Vida y la Salud” and a 2018 grant from Ayudas Fundación BBVA a Equipos de Investigación Científica (to F.S.-M.), and grants PRB3 (IPT17/0019-ISCIII-SGEFI/ERDF), the Fundació Marató TV3 (grant 122/C/2015), and “La Caixa” Banking Foundation (HR17-00016 to FSM and HR17-00247 to J.V.). D.T. is supported by a PhD fellowship from La Caixa Foundation. Work in the Vernos lab was supported by the grant CSD2006-00023 from the Spanish Ministry of Science and Innovation and grants BFU2012-37163 and BFU2015-68726-P from the Spanish Ministry of Economy and Competitiveness. The CRG acknowledges support of the Spanish Ministry of Science and Innovation to the EMBL partnership, the Centro de Excelencia Severo Ochoa, and the CERCA Programme/Generalitat de Catalunya. CIBER Cardiovascular (Fondo de Investigación Sanitaria del Instituto de Salud Carlos III and co-funding by Fondo Europeo de Desarrollo Regional FEDER). The Centro Nacional de Investigaciones Cardiovasculares (CNIC) is supported by the Spanish Ministry of Economy and Competitiveness (MINECO) and the Pro-CNIC Foundation and is a Severo Ochoa Center of Excellence (MINECO award SEV-2015-0505). The Centro Nacional de Biotecnología (CNB) is a Severo Ochoa Center of Excellence (MINECO award SEV 2017-0712).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Why Does COVID-19 Affect Patients with Spinal Cord Injury Milder? A Case-Control Study: Results from Two Observational Cohorts

  • Calvo, Enrique
  • Corbacho-Alonso, Nerea
  • Sastre-Oliva, Tamara
  • Núñez, Estefanía
  • Baena-Galan, Patricia
  • Hernández-Fernández, Germán
  • Rodriguez-Cola, Miguel
  • Jiménez-Velasco, Irena
  • Corrales, Fernando J.
  • Gambarrutta-Malfati, Claudia
  • Gutiérrez-Henares, Francisco
  • López-Dolado, Elisa
  • Gil-Agudo, Ángel
  • Vázquez, Jesús
  • Mourino-Álvarez, Laura
  • Barderas, María Gonzalez
The COVID-19 pandemic represents an unprecedented global challenge in this century. COVID-19 is a viral respiratory infection, yet the clinical characteristics of this infection differ in spinal cord injury patients from those observed in the general population. Cough and asthenia are the most frequent symptoms in this population. Moreover, infected spinal cord injury patients rarely present complications that require admission to an Intensive Care Unit, in contrast to the general population. Thus, there is a clear need to understand how COVID-19 affects spinal cord injury patients from a molecular perspective. Here, we employed an -omics strategy in order to identify variations in protein abundance in spinal cord injury patients with and without COVID-19. After a quantitative differential analysis using isobaric tags and mass spectrometry and a verification phase, we have found differences mainly related to coagulation and platelet activation. Our results suggest a key role of heparin in the response of spinal cord injury patients to COVID-19 infection, showing a significant correlation between these proteins and heparin dose. Although the number of patients is limited, these data may shed light on new therapeutic options to improve the management these patients and, possibly, those of the general population as well., This research was funded by the Consejo Superior de InvestigacionesCientíficas (CSIC) through the project PIE 202020E108, the Instituto de Salud Carlos III through the project PI18/00995 (co-funded by European Regional Development Fund/European Social Fund - “Investing in your future”) and Grant PRB3 (IPT17/0019—ISCIII-SGEFI/ERDF). The MCNU (PGC2018-097019-B-I00) and La Caixa (HR17-00247).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

p38γ and p38δ regulate postnatal cardiac metabolism through glycogen synthase 1

  • Santamans, Ayelén M.
  • Montalvo-Romeral, Valle
  • Mora, Alfonso
  • Lopez, Juan Antonio
  • Gonzalez-Romero, Francisco
  • Jimenez-Blasco, Daniel
  • Rodríguez, Elena
  • Pintor-Chocano, Aránzazu
  • Casanueva-Benítez, Cristina
  • Acín-Pérez, Rebeca
  • Leiva-Vega, Luis
  • Duran, Joan
  • Guinovart, Joan J.
  • Jiménez-Borreguero, Jesús
  • Enríquez, José Antonio
  • Villlalba-Orero, María
  • Bolaños, Juan P.
  • Aspichueta, Patricia
  • Vázquez, Jesús
  • González-Terán, Bárbara
  • Sabio, Guadalupe
During the first weeks of postnatal heart development, cardiomyocytes undergo a major adaptive metabolic shift from glycolytic energy production to fatty acid oxidation. This metabolic change is contemporaneous to the up-regulation and activation of the p38γ and p38δ stress-activated protein kinases in the heart. We demonstrate that p38γ/δ contribute to the early postnatal cardiac metabolic switch through inhibitory phosphorylation of glycogen synthase 1 (GYS1) and glycogen metabolism inactivation. Premature induction of p38γ/δ activation in cardiomyocytes of newborn mice results in an early GYS1 phosphorylation and inhibition of cardiac glycogen production, triggering an early metabolic shift that induces a deficit in cardiomyocyte fuel supply, leading to whole-body metabolic deregulation and maladaptive cardiac pathogenesis. Notably, the adverse effects of forced premature cardiac p38γ/δ activation in neonate mice are prevented by maternal diet supplementation of fatty acids during pregnancy and lactation. These results suggest that diet interventions have a potential for treating human cardiac genetic diseases that affect heart metabolism., G.S. is a YIP EMBO member. B.G.T. was a fellow of the FPI Severo Ochoa CNIC program (SVP-2013-067639) and currently is funded by the AHA-CHF (AHA award number: 818798). V.M.R. is a FPI fellow (BES-2014-069332) and A.M.S. is a fellow of the FPI Severo Ochoa CNIC program (BES-2016-077635). This work was funded by the following grants: to G.S.: funding from the EFSD/Lilly European Diabetes Research Programme Dr Sabio, from Spanish Ministry of Science, Innovation and Universities (MINECO-FEDER SAF2016-79126-R and PID2019-104399RB-I00), Comunidad de Madrid (IMMUNOTHERCAN-CM S2010/BMD-2326 and B2017/BMD-3733) and Fundación Jesús Serra; to P.A.: Ayudas para apoyar grupos de investigación del sistema Universitario Vasco (IT971-16 to P.A.), MCIU/AEI/FEDER, funding from Spanish Ministry of Science, Innovation and Universities (RTI2018-095134-B-100); Excellence Network Grant from MICIU/AEI (SAF2016-81975-REDT and 2018-PN188) to PA and GS; to J.V.: funding from Spanish Ministry of Science, Innovation and Universities (PGC2018-097019-B-I00), the Instituto de Salud Carlos III (Fondo de Investigación Sanitaria grant PRB3 (PT17/0019/0003- ISCIII-SGEFI / ERDF, ProteoRed), and “la Caixa” Banking Foundation (project code HR17-00247); to J.P.B.: funding from Spanish Ministry of Science, Innovation and Universities (PID2019-105699RB-I00, RED2018‐102576‐T) and Escalera de Excelencia (CLU-2017-03); to J.A.E.: funding from Spanish Ministry of Science, Innovation and Universities MINECO (RED2018-102576-T, RTI2018-099357-B-I00), CIBERFES (CB16/10/00282), and HFSP (RGP0016/2018). RAP (XPC/BBV1602 and MIN/RYC1102). The CNIC is supported by the Ministry of Science, Innovation and Universities and the Pro CNIC Foundation, and is a Severo Ochoa Center of Excellence (SEV-2015-0505). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Mapping the Serum Proteome of COVID-19 Patients; Guidance for Severity Assessment

  • Núñez, Estefanía
  • Orera Utrilla, Irene
  • Carmona-Rodríguez, Lorena
  • Paño, José Ramón
  • Vázquez, Jesús
  • Corrales, Fernando J.
Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), whose outbreak in 2019 led to an ongoing pandemic with devastating consequences for the global economy and human health. According to the World Health Organization, COVID-19 has affected more than 481 million people worldwide, with 6 million confirmed deaths. The joint efforts of the scientific community have undoubtedly increased the pace of production of COVID-19 vaccines, but there is still so much uncharted ground to cover regarding the mechanisms of SARS-CoV-2 infection, replication and host response. These issues can be approached by proteomics with unprecedented capacity paving the way for the development of more efficient strategies for patient care. In this study, we present a deep proteome analysis that has been performed on a cohort of 72 COVID-19 patients aiming to identify serum proteins assessing the dynamics of the disease at different age ranges. A panel of 53 proteins that participate in several functions such as acute-phase response and inflammation, blood coagulation, cell adhesion, complement cascade, endocytosis, immune response, oxidative stress and tissue injury, have been correlated with patient severity, suggesting a molecular basis for their clinical stratification. Eighteen protein candidates were further validated by targeted proteomics in an independent cohort of 84 patients including a group of individuals that had satisfactorily resolved SARS-CoV-2 infection. Remarkably, all protein alterations were normalized 100 days after leaving the hospital, which further supports the reliability of the selected proteins as hallmarks of COVID-19 progression and grading. The optimized protein panel may prove its value for optimal severity assessment as well as in the follow up of COVID-19 patients., This study was supported by competitive grants from the Spanish Ministry of Science, Innovation and Universities (PGC2018-097019-B-I00), the Instituto de Salud Carlos III (Fondo de Investigación Sanitaria grant PRB3 (PT17/0019/0003-ISCIII-SGEFI/ERDF, ProteoRed), and “la Caixa” Banking Foundation (project code HR17-00247). The CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the Ministerio de Ciencia e Innovación (MCIN) and the Pro CNIC Foundation), and is a Severo Ochoa Center of Excellence (grant CEX2020-001041-S funded by MICIN/AEI/10.13039/501100011033). The CNB was supported by the Carlos III Health Institute of Spain -Fondos FEDER (EU) (PRB3-ISCIII, supported by grant PT17/0019/0001). Comunidad de Madrid Grant B2017/BMD-3817. Severo Ochoa Project SEV 2017-0712. Intramural CSIC PIE/COVID-19 projects 202020E079 and 202020E108. This research work was also funded by the European Commission—NextGenerationEU (Regulation EU 2020/2094), through CSIC’s Global Health Platform (PTI Salud Global)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Autophagy-linked plasma and lysosomal membrane protein PLAC8 is a key host factor for SARS-CoV-2 entry into human cells

  • Ugalde, Alejandro P.
  • Bretones, Gabriel
  • Rodríguez, David
  • Quesada, Víctor
  • Llorente, Francisco
  • Fernandez-Delgado, Raúl
  • Jiménez-Clavero, Miguel Ángel
  • Vázquez, Jesús
  • Calvo, Enrique
  • Tamargo-Gómez, Isaac
  • Mariño, Guillermo
  • Roiz, David
  • Maeso, Daniel
  • Araujo-Voces, Miguel
  • Español, Yaiza
  • Barceló, Carlos
  • Freije, José M. P.
  • López-Soto, Alejandro
  • López-Otín, Carlos
Better understanding on interactions between SARS-CoV-2andhost cells should help to identify host factors that may be tar-getable to combat infection and COVID-19pathology. To this end,we have conducted a genome-wide CRISPR/Cas9-based loss-of-function screen in human lung cancer cells infected with SARS-CoV-2-pseudotyped lentiviruses. Our results recapitulate manyfindings from previous screens that used full SARS-CoV-2viruses,but also unveil two novel critical host factors: the lysosomal effluxtransporter SPNS1and the plasma and lysosomal membrane pro-tein PLAC8. Functional experiments with full SARS-CoV-2virusesconfirm that loss-of-function of these genes impairs viral entry.We find that PLAC8is a key limiting host factor, whose overexpres-sion boosts viral infection in eight different human lung cancer celllines. Using single-cell RNA-Seq data analyses, we demonstratethat PLAC8is highly expressed in ciliated and secretory cells of therespiratory tract, as well as in gut enterocytes, cell types that arehighly susceptible to SARS-CoV-2infection. Proteomics and cellbiology studies suggest that PLAC8and SPNS1regulate theautophagolysosomal compartment and affect the intracellular fateof endocytosed virions., This work was supported by Instituto de Salud Carlos III(COV20/00652, MS19/00100,  PI20/01267, COV20/00571 and PT17/0019/0003), Ministerio de Ciencia e Innovación (Spain) (PDI2020-118394RB-100, SAF2017-87655-R, PID2021-127534OB-100, and PGC2018-097019-B-I00), “laCaixa” Banking Foundation (HR17-00247) and Consejería de Ciencia, Innovación y Universidad del Gobierno del Principado de Asturias (AYUD/2021/57167). D.R.V and D.M are supported by PhD fellowships from Ministerio de Ciencia e Innovación(Spain)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

TGF-β-Upregulated Lnc-Nr6a1 Acts as a Reservoir of miR-181 and Mediates Assembly of a Glycolytic Complex

  • Polo-Generelo, Salvador
  • Torres, Belén
  • Guerrero-Martínez, José A.
  • Camafeita, Emilio
  • Vázquez, Jesús
  • Reyes, José C.
  • Pintor-Toro, José Antonio
Long non-coding RNAs (lncRNAs) have emerged as key regulators in a wide range of biological processes. Here, we identified a mouse miRNA-host gene lncRNA (Lnc-Nr6a1) upregulated early during epithelial-to-mesenchymal transition (EMT). We show that when lncRNA is processed, it gives rise to two abundant polyadenylated isoforms, lnc-Nr6a1-1 and lnc-Nr6a1-2, and a longer non-polyadenylated microprocessor-driven lnc-pri-miRNA containing clustered pre-miR-181a2 and pre-miR-181b2 hairpins. Ectopic expression of the lnc-Nr6a1-1 or lnc-Nr6a1-2 isoform enhanced cell migration and the invasive capacity of the cells, whereas the expression of the isoforms and miR-181a2 and miR-181b2 conferred anoikis resistance. Lnc-Nr6a1 gene deletion resulted in cells with lower adhesion capacity and reduced glycolytic metabolism, which are restored by lnc-Nr6a1-1 isoform expression. We performed identification of direct RNA interacting proteins (iDRIP) to identify proteins interacting directly with the lnc-Nr6a1-1 isoform. We defined a network of interacting proteins, including glycolytic enzymes, desmosome proteins and chaperone proteins; and we demonstrated that the lnc-Nr6a1-1 isoform directly binds and acts as a scaffold molecule for the assembly of ENO1, ALDOA, GAPDH, and PKM glycolytic enzymes, along with LDHA, supporting substrate channeling for efficient glycolysis. Our results unveil a role of Lnc-Nr6a1 as a multifunctional lncRNA acting as a backbone for multiprotein complex formation and primary microRNAs., This research was funded by Ministerio de Economía y Competitividad, grant number SAF2017-861892-P and PID2020-119732RB-100 to J.A.P.-T. and PGC2018-097019-B-100 and PID2021- 122348NB-100 to J.V., and by la Caixa Banking Foundation, project codes HR17-00247 and HR22-00253 to J.V.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Extracellular vesicles from Listeria monocytogenes-infected dendritic cells alert the innate immune response

  • Izquierdo-Serrano, Raúl
  • Fernández-Delgado, Irene
  • Moreno-Gonzalo, Olga
  • Martín-Gayo, Enrique
  • Calzada-Fraile, Diego
  • Ramírez-Huesca, Marta
  • Jorge, Inmaculada
  • Camafeita, Emilio
  • Abián, Joaquín
  • Vicente-Manzanares, Miguel
  • Veiga, Esteban
  • Vázquez, Jesús
  • Sánchez-Madrid, Francisco
Communication through cell-cell contacts and extracellular vesicles (EVs) enables immune cells to coordinate their responses against diverse types of pathogens. The function exerted by EVs in this context depends on the proteins and nucleic acids loaded into EVs, which elicit specific responses involved in the resolution of infection. Several mechanisms control protein and nucleic acid loading into EVs; in this regard, acetylation has been described as a mechanism of cellular retention during protein sorting to exosomes. HDAC6 is a deacetylase involved in the control of cytoskeleton trafficking, organelle polarity and cell migration, defense against Listeria monocytogenes (Lm) infection and other immune related functions. Here, we show that the protein content of dendritic cells (DCs) and their secreted EVs (DEVs) vary during Lm infection, is enriched in proteins related to antiviral functions compared to non-infected cells and depends on HDAC6 expression. Analyses of the post-translational modifications revealed an alteration of the acetylation and ubiquitination profiles upon Lm infection both in DC lysates and DEVs. Functionally, EVs derived from infected DCs upregulate anti-pathogenic genes (e.g. inflammatory cytokines) in recipient immature DCs, which translated into protection from subsequent infection with vaccinia virus. Interestingly, absence of Listeriolysin O in Lm prevents DEVs from inducing this anti-viral state. In summary, these data underscore a new mechanism of communication between bacteria-infected DC during infection as they alert neighboring, uninfected DCs to promote antiviral responses., This study was supported by grant PDI-2020-120412RB-I00, PDC2021-121797-I00, BIO2015-67580-P and PGC2018-097019-B-I00 from the Spanish Ministry of Economy and Competitiveness (MINECO), grant S2017/BMD-3671-INFLAMUNE-CM from the Comunidad de Madrid, a grant from the Ramón Areces Foundation “Ciencias de la Vida y la Salud” (XIX Concurso-2018), “la Caixa” Banking Foundation (grants HR17-00016 and HR17-00247), BIOIMID (PIE13/041) and PRB3 (IPT17/0019 - ISCIII-SGEFI/ERDF, ProteoRed) from Instituto de Salud Carlos III, CIBER Cardiovascular (CB16/11/00272), and Fondo de Investigación Sanitaria del Instituto de Salud Carlos III and co-funding by Fondo Europeo de Desarrollo Regional FEDER). IF-D is supported by a Fellowship from the Spanish Ministry of Science, Innovation, and Universities (FPU15/02539). DC-F is supported by a Fellowship from “la Caixa” Foundation (LCF/BQ/DR19/11740010). The CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the Ministerio de Ciencia e Innovación (MCIN) and the Pro CNIC Foundation, and is a Severo Ochoa Center of Excellence (CEX2020-001041-S). Funding agencies did not intervene in the design of the studies, with no copyright over the study.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Specialized proresolving mediators protect against experimental autoimmune myocarditis by modulating Ca2+ handling and NRF2 activation

  • Val-Blasco, Almudena
  • Prieto, Patricia
  • Iñigo Jaén, Rafael
  • Gil-Fernández, Marta
  • Pajares, Marta
  • Domenech, N.
  • Terrón, Verónica
  • Tamayo, María
  • Jorge, Inmaculada
  • Vázquez, Jesús
  • Bueno-Sen, A.
  • Vallejo-Cremades, Maria T.
  • Pombo-Otero, Jorge
  • Sánchez-García, Sergio
  • Ruiz-Hurtado, Gema
  • Gómez, Ana María
  • Zaragoza, Carlos
  • Crespo-Leiro, M. G.
  • López-Collazo, Eduardo
  • Cuadrado, Antonio
  • Delgado, Carmen
  • Boscá, Lisardo
  • Fernández-Velasco, María
Specialized proresolving mediators and, in particular, 5(S), (6)R, 7-trihydroxyheptanoic acid methyl ester (BML-111) emerge as new therapeutic tools to prevent cardiac dysfunction and deleterious cardiac damage associated with myocarditis progression. The cardioprotective role of BML-111 is mainly caused by the prevention of increased oxidative stress and nuclear factor erythroid-derived 2-like 2 (NRF2) down-regulation induced by myocarditis. At the molecular level, BML-111 activates NRF2 signaling, which prevents sarcoplasmic reticulum–adenosine triphosphatase 2A down-regulation and Ca2+ mishandling, and attenuates the cardiac dysfunction and tissue damage induced by myocarditis., This work was supported by the Spanish Ministry of Economy and Competitiveness and the European Regional Development Fund (SAF-2017-84777R), Instituto de Salud Carlos III (ISCIII) (PI17/01093, PI17/01344, and PI20/01482), Sociedad Española de Cardiología, Proyecto Traslacional 2019 and Asociación del Ritmo Cardiaco (SEC, España), Proyecto Asociación Insuficiencia Cardiaca (Trasplante Cardiaco) 2020, Fondo Europeo de Desarrollo Regional, Fondo Social Europeo, and CIBERCV, a network funded by ISCIII, Spanish Ministry of Science, Innovation and Universities (PGC2018-097019-B-I00), Ministerio de Economía, Industria y Competitividad/Agencia Estatal de Investigación 10.13039/501100011033 PID2020-113238RB-I00, PID2019-105600RB-I00, the Instituto de Salud Carlos III (Fondo de Investigación Sanitaria grant PRB3 [PT17/0019/0003-ISCIII-SGEFI/ERDF, ProteoRed]), and “la Caixa” Foundation (project code HR17-00247). The Centro Nacional de Investigaciones Cardiovasculares is supported by the ISCIII, the Ministerio de Ciencia, Innovación y Universidades. Dr Ruiz-Hurtado is Miguel Servet I researcher of ISCIII (CP15/00129 Carlos III Health Institute). Dr Tamayo and R.I. Jaén, and M. Gil-Fernández were or currently are PhD students funded by the Formación de Profesorado Universitario program of the Spanish Ministry of Science, Innovation and Universities (FPU17/06135; FPU16/00827, FPU1901973).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Interferon-stimulated gene 15 pathway is a novel mediator of endothelial dysfunction and aneurysms development in angiotensin II infused mice through increased oxidative stress

  • González-Amor, María
  • García-Redondo, Ana B.
  • Jorge, Inmaculada
  • Zalba, Guillermo
  • Becares, Martina
  • Ruiz-Rodríguez, María J.
  • Rodríguez-Sinovas, Cristina
  • Bermeo, Hugo
  • Rodrigues-Díez, Raquel
  • Ríos, Francisco J,
  • Montezano, Augusto C.
  • Martínez-González, José
  • Vázquez, Jesús
  • Redondo, Juan Miguel
  • Touyz, Rhian M.
  • Guerra, Susana
  • Salaices, Mercedes
  • Briones, Ana M.
AIMS: Interferon-stimulated gene 15 (ISG15) encodes a ubiquitin-like protein that induces a reversible post-translational modification (ISGylation) and can also be secreted as a free form. ISG15 plays an essential role as host-defence response to microbial infection; however, its contribution to vascular damage associated with hypertension is unknown. METHODS AND RESULTS: Bioinformatics identified ISG15 as a mediator of hypertension-associated vascular damage. ISG15 expression positively correlated with systolic and diastolic blood pressure and carotid intima-media thickness in human peripheral blood mononuclear cells. Consistently, Isg15 expression was enhanced in aorta from hypertension models and in angiotensin II (AngII)-treated vascular cells and macrophages. Proteomics revealed differential expression of proteins implicated in cardiovascular function, extracellular matrix and remodelling, and vascular redox state in aorta from AngII-infused ISG15-/- mice. Moreover, ISG15-/- mice were protected against AngII-induced hypertension, vascular stiffness, elastin remodelling, endothelial dysfunction, and expression of inflammatory and oxidative stress markers. Conversely, mice with excessive ISGylation (USP18C61A) show enhanced AngII-induced hypertension, vascular fibrosis, inflammation and reactive oxygen species (ROS) generation along with elastin breaks, aortic dilation, and rupture. Accordingly, human and murine abdominal aortic aneurysms showed augmented ISG15 expression. Mechanistically, ISG15 induces vascular ROS production, while antioxidant treatment prevented ISG15-induced endothelial dysfunction and vascular remodelling. CONCLUSION: ISG15 is a novel mediator of vascular damage in hypertension through oxidative stress and inflammation., This work was supported by the Ministerio de Ciencia e Innovación and Fondo Europeo de Desarrollo Regional (FEDER)/FSE (SAF2016-80305P; SAF2017-88089-R; SAF2016-79151-R; RTI2018-099246-B-I00), Ministerio de Innovación, Cultura y Deportes (PGC2018-097019-B-I00), Instituto de Salud Carlos III (ISCIII; FIS PI18/0919); Comunidad de Madrid (CM) (AORTASANA B2017/BMD-3676) FEDER-a way to build Europe, Bayer AG (2019-09-2433), CM-Universidad Autónoma de Madrid (SI1-PJI-2019-00321), and British Heart Foundation (CH/12/4/29762; RE//18/6/34217). M.G.-A. was supported by an FPI-UAM fellowship, R.R.-D. by a Juan de la Cierva contract (IJCI-2017-31399), and A.C.M. by a Walton Fellowship, University of Glasgow. The CNIC is supported by ISCIII, the Ministerio de Ciencia e Innovación, and the Pro CNIC Foundation, and is a Severo Ochoa Center of Excellence (SEV-2015-0505).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Capillary pruning couples tissue perfusion and oxygenation with cardiomyocyte maturation in the postnatal mouse heart

  • Santamaría, Ricardo
  • Cruz-Caballero, Javier
  • Gkontra, Polyxeni
  • Jiménez-Montiel, Alberto
  • Clemente, Cristina
  • López, Juan A.
  • Villalba-Orero, María
  • Vázquez, Jesús
  • Hutloff, Andreas
  • Lara-Pezzi, Enrique
  • Arroyo, Alicia G.
19 p.-6 fig., Introduction: Removal of poorly perfused capillaries by pruning contributes to remodeling the microvasculature to optimize oxygen and nutrient delivery. Blood flow drives this process by promoting the intravascular migration of endothelial cells in developing networks, such as in the yolk sac, zebrafish brain or postnatal mouse retina., Methods: In this study, we have implemented innovative tools to recognize capillary pruning in the complex 3D coronary microvasculature of the postnatal mouse heart. We have also experimentally tested the impact of decreasing pruning on the structure and function of this network by altering blood flow with two different vasodilators: losartan and prazosin., Results: Although both drugs reduced capillary pruning, a combination of experiments based on ex vivo imaging, proteomics, electron microscopy and in vivo functional approaches showed that losartan treatment resulted in an inefficient coronary network, reduced myocardial oxygenation and metabolic changes that delayed the arrest of cardiomyocyte proliferation, in contrast to the effects of prazosin, probably due to its concomitant promotion of capillary expansion., Discussion: Our work demonstrates that capillary pruning contributes to proper maturation and function of the heart and that manipulation of blood flow may be a novel strategy to refine the microvasculature and improve tissue perfusion after damage., This work was supported by grants SAF 2017-83229-R funded by MCIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe” and PID2020-112981RB-I00 funded byMCIN/AEI/10.13039/501100011033 (to AA), Deutsche Forschungsgemeinschaft grant HU 1294/8-1 (to AH)and PGC 2018-097019-B-I00, PID 2021-122348NB-I00, PLEC 2022-009235 and PLEC 2022-009298 from MCIN, P2022/BMD-7333l from CAM and HR17-00247 and HR22-00253 from “La Caixa” Banking Foundation (to JV). RS was a fellow of the FPI Severo Ochoa program CNIC (BES-2016-076636) funded by MCIN/AEI/10.13039/501100011033 and JC-C is a FPI fellow (PRE 2021-099875) funded by MCIN/AEI/10.13039/501100011033 and by “ESF Investing in your future”. CNIC is supported by the MCIN and the Pro CNIC Foundation, and is a Severo Ochoa Center of Excellence (CEX2020-001041-S) funded by MCIN/AEI/10.13039/501100011033., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

MCJ: A mitochondrial target for cardiac intervention in pulmonary hypertension

  • Santamans, Ayelén M.
  • Cicuéndez, Beatriz
  • Mora, Alfonso
  • Villalba-Orero, María
  • Rajlic, Sanela
  • Crespo, María
  • Vo, Paula
  • Jerome, Madison
  • Macías, Álvaro
  • López, Juan Antonio
  • Leiva, Magdalena
  • Rocha, Susana F.
  • León, Marta
  • Rodríguez, Elena
  • Leiva-Vega, Luis
  • Pintor-Chocano, Aránzazu
  • García-Lunar, Inés
  • García-Álvarez, Ana
  • Hernansanz-Agustín, Pablo
  • Peinado, Víctor
  • Barberà, Joan Albert
  • Ibáñez, Borja
  • Vázquez, Jesús
  • Spinelli, Jessica B.
  • Daiber, Andreas
  • Oliver, Eduardo
  • Sabio, Guadalupe
17 p.-6 fig.-2 tab., Pulmonary hypertension (PH) can affect both pulmonary arterial tree and cardiac function, often leading to right heart failure and death. Despite the urgency, the lack of understanding has limited the development of effective cardiac therapeutic strategies. Our research reveals that MCJ modulates mitochondrial response to chronic hypoxia. MCJ levels elevate under hypoxic conditions, as in lungs of patients affected by COPD, mice exposed to hypoxia, and myocardium from pigs subjected to right ventricular (RV) overload. The absence of MCJ preserves RV function, safeguarding against both cardiac and lung remodeling induced by chronic hypoxia. Cardiac-specific silencing is enough to protect against cardiac dysfunction despite the adverse pulmonary remodeling. Mechanistically, the absence of MCJ triggers a protective preconditioning state mediated by the ROS/mTOR/HIF-1α axis. As a result, it preserves RV systolic function following hypoxia exposure. These discoveries provide a potential avenue to alleviate chronic hypoxia-induced PH, highlighting MCJ as a promising target against this condition., This study was financially supported by the following: Interacciones celulares y sistémicas entre el cáncer y la señalización metabólica, exp: RED2022-134397-T (G.S.); Proyectos I+D+i 2019 - Proyecto MINECO-PID2019-104399RB-I00 financiado por MCIN/AEI/10.13039/501100011033 (G.S.); Proyectos de I+D de Generación de Conocimiento 2018 funded by Ministerio de Economía y Competitividad (PGC2018-097019-B-I00) (G.S.); PreMed-Exp: PMP21/00057 (G.S.); Fundación Jesús Serra (G.S.); EFSD/Lilly European Diabetes Research Programme (G.S.); BBVA Foundation Leonardo Grants program for Researchers and Cultural Creators (Investigadores-BBVA-2017) (G.S.); Fundación AECC PROYE19047SABI (G.S.); Comunidad de Madrid IMMUNOTHERCAN-CM S2010/BMD-2326 (G.S.); FPI Severo Ochoa CNIC program (BES-2016-077635) (A.M.S.); JDC-2020 Incorporación (IJC2020-042679-I) (P.H.-A.); Fondo Europeo de Desarrollo Regional (FEDER) Instituto de Salud Carlos III-Fondo de Investigación Sanitaria PI17/00995 (A.G.-Á.); Fondo Europeo de Desarrollo Regional (FEDER) Instituto de Salud Carlos III-Fondo de Investigación Sanitaria (PI20/00742) (A.G.-Á.); Intensificación AES2019 (AGA); Fundación “La Caixa”: Macromoleculopathies (LCF/PR/HR19/52160013) of the call HEALTH RESEARCH 2018 (Á.Ma.); Programa de Atracción de Talento (2017-T1/BMD-5185) funded by Comunidad de Madrid (E.O.); Ramón y Cajal grant (RYC2020-028884-I) funded by MCIN/AEI/10.13039/501100011033 and by “ESF Investing in your future” (E.O.); Juan de la Cierva Incorporación Grant (IJCI-2016-27698) (M.V.O.); Worcester Foundation for Biomedical Research (J.B.S.); Boehringer Ingelheim Foundation (collaborative research group “Novel and neglected cardiovascular risk factors: molecular mechanisms and therapeutics”) (A.D.); Foundation Heart of Mainz (A.D.); DZHK (German Center for Cardiovascular Research), Partner Site Rhine-Main, Mainz, Germany (A.D.); Ministerio de Ciencia e Innovación (PGC2018-097019-B-I00, PID2021-122348NB-I00, PLEC2022-009235, and PLEC2022-009298) (J.V.); Fundación “La Caixa” (HR17-00247 and HR22-00253) (J.V.); Carlos III Institute of Health-Fondo de Investigación Sanitaria grant PRB3 (PT17/0019/0003- ISCIII-SGEFI/ERDF, ProteoRed) (J.V.); and Comunidad de Madrid (IMMUNO-VAR, P2022/BMD-7333) (J.V.). The CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the Ministerio de Ciencia e Innovación (MCIN), and the Pro CNIC Foundation and is a Severo Ochoa Center of Excellence (grant CEX2020-001041-S funded by MICIN/AEI/10.13039/501100011033)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Chaperonin CCT controls extracellular vesicle production and cell metabolism through kinesin dynamics

  • Rojas-Gómez, Amelia
  • Dosil, S. G.
  • Chichón, Francisco Javier
  • Fernández-Gallego, Nieves
  • Ferrarini, Alessia
  • Calvo, Enrique
  • Calzada-Fraile, Diego
  • Requena, Silvia
  • Otón, Joaquín
  • Serrano, Álvaro
  • Tarifa, Rocío
  • Arroyo, Montserrat
  • Sorrentino, A.
  • Pereiro, Eva
  • Vázquez, Jesús
  • Valpuesta, José M.
  • Sánchez-Madrid, Francisco
  • Martín-Cófreces, Noa Beatriz
Cell proteostasis includes gene transcription, protein translation, folding of de novo proteins, post-translational modifications, secretion, degradation and recycling. By profiling the proteome of extracellular vesicles (EVs) from T cells, we have found the chaperonin complex CCT, involved in the correct folding of particular proteins. By limiting CCT cell-content by siRNA, cells undergo altered lipid composition and metabolic rewiring towards a lipid-dependent metabolism, with increased activity of peroxisomes and mitochondria. This is due to dysregulation of the dynamics of interorganelle contacts between lipid droplets, mitochondria, peroxisomes and the endolysosomal system. This process accelerates the biogenesis of multivesicular bodies leading to higher EV production through the dynamic regulation of microtubule-based kinesin motors. These findings connect proteostasis with lipid metabolism through an unexpected role of CCT., Comunidad de Madrid, Grant/Award Numbers: S2022/BMD-7209-INTEGRAMUNE-CM, P2022/BMD-7333; Carlos III Institute of Health-Fondo de Investigacion Sanitaria, Grant/Award Numbers: PRB3 (IPT17/0019 - ISCIII-SGEFI / ERDF), CIBER Cardiovascular (CIBERCV); La Caixa Banking Foundation, Grant/Award Numbers: HR17-00016, HR17-00247, HR22-00253, HR22-00722; consorcio para la construcción equipamiento y explotación del laboratorio de luz sincrotrón, Grant/Award Numbers: 2015021148, 2016021638; Agencia Estatal de Investigación, Grant/Award Numbers: PDC2021-121719-I00, PLEC2022-009298, PID-2020-120412RB-I00, PGC2018-097019-B-I00, PID2021-122348NB-I00, PID2019-105872GB- I00/AEI/10.13039/501100011033, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Immune synapse formation promotes lipid peroxidation and MHC-I upregulation in licensed dendritic cells for efficient priming of CD8+ T cells

  • Calzada-Fraile, Diego
  • Iborra, Salvador
  • Ramírez-Huesca, Marta
  • Jorge, Inmaculada
  • Dotta, Enrico
  • Hernández-García, Elena
  • Martín-Cófreces, Noa Beatriz
  • Nistal-Villán, Estanislao
  • Veiga, Esteban
  • Vázquez, Jesús
  • Pasqual, Giulia
  • Sánchez-Madrid, Francisco
Antigen cognate dendritic cell (DC)-T cell synaptic interactions drive activation of T cells and instruct DCs. Upon receiving CD4+ T cell help, post-synaptic DCs (psDCs) are licensed to generate CD8+ T cell responses. However, the cellular and molecular mechanisms that enable psDCs licensing remain unclear. Here, we describe that antigen presentation induces an upregulation of MHC-I protein molecules and increased lipid peroxidation on psDCs in vitro and in vivo. We also show that these events mediate DC licensing. In addition, psDC adoptive transfer enhances pathogen-specific CD8+ T responses and protects mice from infection in a CD8+ T cell-dependent manner. Conversely, depletion of psDCs in vivo abrogates antigen-specific CD8+ T cell responses during immunization. Together, our data show that psDCs enable CD8+ T cell responses in vivo during vaccination and reveal crucial molecular events underlying psDC licensing., This study was supported by the Spanish Ministry of Science and Innovation (grants PID2020-120412RB-I00, PDC2021-121797-I00, PGC2018-097019-BI00, PID2021-122348NB-I00, PLEC2022-009235, PLEC2022-009298, PID2021-125415OB-I00, and PID2019-105761RB-I00); Comunidad de Madrid (INTEGRAMUNE, P2022/BMD7209 and IMMUNO-VAR, P2022/BMD-7333); Ramón Areces Foundation “Ciencias de la Vida y la Salud” (XIX Concurso-2018); “la Caixa” Banking Foundation (grants HR17-00016, HR17-00247, and HR22-00253); ProteoRed from Instituto de Salud Carlos III (PT17/0019/0003- ISCIII-SGEFI / ERDF); CIBER Cardiovascular (CB16/11/00272, CB16/11/00277); Agencia Estatal de Investigación (AEI); Fondo de Investigación Sanitaria del Instituto de Salud Carlos III; co-funding by Fondo Europeo de Desarrollo Regional (FEDER); and European Research Council Starting Grant SYNVIVO 853179. D.C.-F. is supported by an INPhINIT Retaining Fellowship from “la Caixa” Foundation (LCF/BQ/DR19/11740010). S.I. is supported by a RYC-2016-19463 fellowship. E.H. is supported by an FPI fellowship (PRE2019-087509). We thank Miguel Vicente-Manzanares for critically reading the manuscript. The CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the Ministerio de Ciencia e Innovación (MCIN) and the Pro CNIC Foundation, and is a Severo Ochoa Center of Excellence (grant CEX2020-001041-S funded by MICIN/AEI/10.13039/501100011033)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Galectin-1 prevents pathological vascular remodeling in atherosclerosis and abdominal aortic aneurysm

  • Roldán-Montero, R
  • Pérez-Sáez, Juan M.
  • Cerro-Pardo, Isabel
  • Oller, Jorge
  • Martinez-Lopez, Diego
  • Nuñez, Estefania
  • Maller, Sebastian M.
  • Gutierrez-Muñoz, Carmen
  • Mendez-Barbero, Nerea
  • Escola-Gil, Joan C.
  • Michel, Jean-Baptiste
  • Mittelbrunn, Maria
  • Vázquez, Jesús
  • Blanco-Colio, Luis M.
  • Rabinovich, Gabriel A.
  • Martín-Ventura, Jose Luis
Pathological vascular remodeling is the underlying cause of atherosclerosis and abdominal aortic aneurysm (AAA). Here, we analyzed the role of galectin-1 (Gal-1), a β-galactoside-binding protein, as a therapeutic target for atherosclerosis and AAA. Mice lacking Gal-1 (Lgals1-/-) developed severe atherosclerosis induced by pAAV/D377Y-mPCSK9 adenovirus and displayed higher lipid levels and lower expression of contractile markers of vascular smooth muscle cells (VSMCs) in plaques than wild-type mice. Proteomic analysis of Lgals1-/- aortas showed changes in markers of VSMC phenotypic switch and altered composition of mitochondrial proteins. Mechanistically, Gal-1 silencing resulted in increased foam cell formation and mitochondrial dysfunction in VSMCs, while treatment with recombinant Gal-1 (rGal-1) prevented these effects. Furthermore, rGal-1 treatment attenuated atherosclerosis and elastase-induced AAA, leading to higher contractile VSMCs in aortic tissues. Gal-1 expression decreased in human atheroma and AAA compared to control tissue. Thus, Gal-1-driven circuits emerge as potential therapeutic strategies in atherosclerosis and AAA., This study was funded by the Spanish MINECO (PID2019-106814RB-I00 and PGC2018-097019-B-I00), CAM (Complemento II-CM, S2017/BMD-3673), Fondo de Investigaciones Sanitarias ISCiii-FEDER [Biobancos RD09/0076/00101 and PRB3 (IPT17/0019, ProteoRed)], and FEDER “Una manera de hacer Europa.” CIBERCV and CIBERDEM are Instituto de Salud Carlos III projects. This work also received funding from “La Caixa” Banking Foundation under the project code HR17-00247. The CNIC is supported by Instituto de Salud Carlos III (ISCIII), Ministerio de Ciencia, Innovación y Universidades (MCNU), and Pro CNIC Foundation and is a Severo Ochoa Center of Excellence (SEV-2015-0505). Further support was provided by Santander-UAM, Agencia Nacional de Promoción de la Investigación, el Desarrollo Tecnológico y la Innovación (PICT 2010-870, Argentina), Fundación Sales, and Fundación Bunge y Born (Argentina). We thank the support of Ferioli, Ostry, and Caraballo families
Docta Complutense
Publicación Artículo científico (JournalArticle)

MCJ: A mitochondrial target for cardiac intervention in pulmonary hypertension

  • Santamans, Ayelén M.
  • Cicuéndez, Beatriz
  • Mora, Alfonso
  • Rajlic, Sanela
  • Crespo, María
  • Vo, Paula
  • Jerome, Madison
  • Macías, Álvaro
  • López, Juan Antonio
  • Rocha, Susana F.
  • León, Marta
  • Rodríguez, Elena
  • Leiva, Luis
  • Pintor Chocano, Aránzazu
  • García Lunar, Inés
  • García-Álvarez, Ana
  • Hernansanz-Agustín, Pablo
  • Peinado, Víctor I.
  • Barberá, Joan Albert
  • Ibañez, Borja
  • Vázquez, Jesús
  • Spinelli, Jessica B.
  • Daiber, Andreas
  • Oliver, Eduardo
  • Sabio, Guadalupe
  • Villalba Orero, María
  • Leiva Arjona, María Magdalena
Pulmonary hypertension (PH) can affect both pulmonary arterial tree and cardiac function, often leading to right heart failure and death. Despite the urgency, the lack of understanding has limited the development of effective cardiac therapeutic strategies. Our research reveals that MCJ modulates mitochondrial response to chronic hypoxia. MCJ levels elevate under hypoxic conditions, as in lungs of patients affected by COPD, mice exposed to hypoxia, and myocardium from pigs subjected to right ventricular (RV) overload. The absence of MCJ preserves RV function, safeguarding against both cardiac and lung remodeling induced by chronic hypoxia. Cardiac-specific silencing is enough to protect against cardiac dysfunction despite the adverse pulmonary remodeling. Mechanistically, the absence of MCJ triggers a protective preconditioning state mediated by the ROS/mTOR/HIF-1α axis. As a result, it preserves RV systolic function following hypoxia exposure. These discoveries provide a potential avenue to alleviate chronic hypoxia-induced PH, highlighting MCJ as a promising target against this condition.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Galectin-1 prevents pathological vascular remodeling in atherosclerosis and abdominal aortic aneurysm

  • Roldán-Montero, Raquel|||0000-0003-0117-2608
  • Pérez-Sáez, Juan M.|||0000-0002-6722-5760
  • Cerro-Pardo, Isabel|||0000-0002-2542-5051
  • Oller Pedrosa, Jorge|||0000-0002-2224-2954
  • Martínez-López, Diego
  • Nuñez, Estefania|||0000-0002-0876-1264
  • Maller, Sebastian M.|||0000-0001-5536-7596
  • Gutiérrez Muñoz, Carmen|||0000-0001-8975-6135
  • Mendez-Barbero, Nerea|||0000-0003-1620-3067
  • Escolà-Gil, Joan Carles|||0000-0001-9021-2485
  • Michel, Jean-Baptiste
  • Mittelbrunn, Maria|||0000-0003-3487-8762
  • Vázquez, Jesús|||0000-0003-1461-5092
  • Blanco-Colio, Luis Miguel|||0000-0002-1560-6609
  • Rabinovich, Gabriel A.|||0000-0002-0947-8735
  • Martin-Ventura, Jose L.|||0000-0003-2090-8641
Pathological vascular remodeling is the underlying cause of atherosclerosis and abdominal aortic aneurysm (AAA). Here, we analyzed the role of galectin-1 (Gal-1), a β-galactoside-binding protein, as a therapeutic target for atherosclerosis and AAA. Mice lacking Gal-1 (Lgals1 -/- ) developed severe atherosclerosis induced by pAAV/D377Y-mPCSK9 adenovirus and displayed higher lipid levels and lower expression of contractile markers of vascular smooth muscle cells (VSMCs) in plaques than wild-type mice. Proteomic analysis of Lgals1 -/- aortas showed changes in markers of VSMC phenotypic switch and altered composition of mitochondrial proteins. Mechanistically, Gal-1 silencing resulted in increased foam cell formation and mitochondrial dysfunction in VSMCs, while treatment with recombinant Gal-1 (rGal-1) prevented these effects. Furthermore, rGal-1 treatment attenuated atherosclerosis and elastase-induced AAA, leading to higher contractile VSMCs in aortic tissues. Gal-1 expression decreased in human atheroma and AAA compared to control tissue. Thus, Gal-1-driven circuits emerge as potential therapeutic strategies in atherosclerosis and AAA. Galectin-1 plays an essential role in prevention of atherosclerosis and abdominal aortic aneurysm.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Malondialdehyde-modified HDL particles elicit a specific IgG response in abdominal aortic aneurysm

  • Rodríguez-Carrio, J.
  • Cerro-Pardo, Isabel|||0000-0002-2542-5051
  • Lindholt, Jes S.|||0000-0001-9536-4488
  • Bonzon-Kulichenko, Elena|||0000-0003-0852-7520
  • Martínez-López, Diego
  • Roldán-Montero, R.
  • Escolà-Gil, Joan Carles|||0000-0001-9021-2485
  • Michel, J.B.
  • Blanco-Colio, Luis Miguel|||0000-0002-1560-6609
  • Vázquez, Jesús|||0000-0003-1461-5092
  • Suárez, A.
  • Martín-Ventura, J.L.
High Density Lipoprotein (HDL) plays a protective role in abdominal aortic aneurysm (AAA); however, recent findings suggest that oxidative modifications could lead to dysfunctional HDL in AAA. This study aimed at testing the effect of oxidized HDL on aortic lesions and humoral immune responses in a mouse model of AAA induced by elastase, and evaluating whether antibodies against modified HDL can be found in AAA patients. HDL particles were oxidized with malondialdehyde (HDL-MDA) and the changes were studied by biochemical and proteomics approaches. Experimental AAA was induced in mice by elastase perfusion and then mice were treated with HDL-MDA, HDL or vehicle for 14 days. Aortic lesions were studied by histomorphometric analysis. Levels of anti-HDL-MDA IgG antibodies were measured by an in-house immunoassay in the mouse model, in human tissue-supernatants and in plasma samples from the VIVA cohort. HDL oxidation with MDA was confirmed by enhanced susceptibility to diene formation. Proteomics demonstrated the presence of MDA adducts on Lysine residues of HDL proteins, mainly ApoA-I. MDA-modification of HDL abrogated the protective effect of HDL on cultured endothelial cells as well as on AAA dilation in mice. Exposure to HDL-MDA elicited an anti-HDL-MDA IgG response in mice. Anti-HDL-MDA were also detected in tissue-conditioned media from AAA patients, mainly in intraluminal thrombus. Higher plasma levels of anti-HDL-MDA IgG antibodies were found in AAA patients compared to controls. Anti-HDL-MDA levels were associated with smoking and were independent predictors of overall mortality in AAA patients. Overall, MDA-oxidized HDL trigger a specific humoral immune response in mice. Besides, antibodies against HDL-MDA can be detected in tissue and plasma of AAA patients, suggesting its potential use as surrogate stable biomarkers of oxidative stress in AAA.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Comparison of covid-19 and non-covid-19 pneumonia in down syndrome

  • Real de Asua, Diego
  • Mayer, Miguel Angel|||0000-0003-0362-6298
  • Del Carmen Ortega, María
  • Borrel, Jose M.
  • de Jesús Bermejo, Teresa
  • González-lamuño, Domingo|||0000-0002-7578-241X
  • Manso, Coral
  • Moldenhauer, Fernando|||0000-0002-6259-8226
  • Carmona Iragui, Maria|||0000-0001-6914-2339
  • Hüls, Anke|||0000-0002-6005-417X
  • Sherman, Stephanie L.
  • Strydom, Andre
  • Torre, Rafael de la|||0000-0002-6765-1866
  • Dierssen, Mara|||0000-0003-0853-6865
Whether the increased risk for coronavirus disease 2019 (COVID-19) hospitalization and death observed in Down syndrome (DS) are disease specific or also occur in individuals with DS and non-COVID-19 pneumonias is unknown. This retrospective cohort study compared COVID-19 cases in persons with DS hospitalized in Spain reported to the Trisomy 21 Research Society COVID- 19 survey (n = 86) with admissions for non-COVID-19 pneumonias from a retrospective clinical database of the Spanish Ministry of Health (n = 2832 patients). In-hospital mortality rates were significantly higher for COVID-19 patients (26.7% vs. 9.4%), especially among individuals over 40 and patients with obesity, dementia, and/or epilepsy. The mean length of stay of deceased patients with COVID-19 was significantly shorter than in those with non-COVID-19 pneumonias. The rate of admission to an ICU in patients with DS and COVID-19 (4.3%) was significantly lower than that reported for the general population with COVID-19. Our findings confirm that acute SARS-CoV-2 infection leads to higher mortality than non-COVID-19 pneumonias in individuals with DS, especially among adults over 40 and those with specific comorbidities. However, differences in access to respiratory support might also account for some of the heightened mortality of individuals with DS with COVID-19.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Unbiased plasma proteomics discovery of biomarkers for improved detection of subclinical atherosclerosis

  • Nuñez, Estefania|||0000-0002-0876-1264
  • Fuster, Valentín
  • Gómez-Serrano, María
  • Valdivielso, José Manuel|||0000-0003-1343-0184
  • Fernández-Alvira, Juan Miguel
  • Martínez-López, Diego
  • Rodríguez, José Manuel
  • Bonzon-Kulichenko, Elena|||0000-0003-0852-7520
  • Calvo, Enrique
  • Alfayate, Alvaro
  • Bermúdez-López, Marcelino|||0000-0002-3188-4158
  • Escolà-Gil, Joan Carles|||0000-0001-9021-2485
  • Fernández-Friera, Leticia
  • Cerro-Pardo, Isabel|||0000-0002-2542-5051
  • Mendiguren, José María
  • Sánchez-Cabo, Fátima|||0000-0003-1881-1664
  • Sanz Salvo, Javier
  • Ordovás, José María
  • Blanco-Colio, Luis Miguel|||0000-0002-1560-6609
  • García-Ruiz, José Manuel
  • Ibañez, Borja|||0000-0002-5036-254X
  • Lara-Pezzi, Enrique
  • Fernández-Ortiz, Antonio
  • Martín-Ventura, José Luis
  • Vázquez, Jesús|||0000-0003-1461-5092
Background: Imaging of subclinical atherosclerosis improves cardiovascular risk prediction on top of traditional risk factors. However, cardiovascular imaging is not universally available. This work aims to identify circulating proteins that could predict subclinical atherosclerosis. Methods: Hypothesis-free proteomics was used to analyze plasma from 444 subjects from PESA cohort study (222 with extensive atherosclerosis on imaging, and 222 matched controls) at two timepoints (three years apart) for discovery, and from 350 subjects from AWHS cohort study (175 subjects with extensive atherosclerosis on imaging and 175 matched controls) for external validation. A selected three-protein panel was further validated by immunoturbidimetry in the AWHS population and in 2999 subjects from ILERVAS cohort study. Findings: PIGR, IGHA2, APOA, HPT and HEP2 were associated with subclinical atherosclerosis independently from traditional risk factors at both timepoints in the discovery and validation cohorts. Multivariate analysis rendered a potential three-protein biomarker panel, including IGHA2, APOA and HPT. Immunoturbidimetry confirmed the independent associations of these three proteins with subclinical atherosclerosis in AWHS and ILERVAS. A machine-learning model with these three proteins was able to predict subclinical atherosclerosis in ILERVAS (AUC [95%CI]:0.73 [0.70-0.74], p < 1 × 10), and also in the subpopulation of individuals with low cardiovascular risk according to FHS 10-year score (0.71 [0.69-0.73], p < 1 × 10). Interpretation: Plasma levels of IGHA2, APOA and HPT are associated with subclinical atherosclerosis independently of traditional risk factors and offers potential to predict this disease. The panel could improve primary prevention strategies in areas where imaging is not available.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Non-invasive electromechanical assessment during atrial fibrillation identifies underlying atrial myopathy alterations with early prognostic value

  • Enríquez-Vázquez, Daniel
  • Quintanilla, Jorge G.|||0000-0002-2227-3507
  • García-Escolano, Alba|||0000-0002-4649-4603
  • Couselo-Seijas, Marinela|||0000-0001-6548-477X
  • Simón-Chica, Ana|||0000-0002-0664-0397
  • Lee, Peter
  • Alfonso-Almazán, José Manuel
  • Mahía, Patricia|||0000-0002-5136-247X
  • Redondo-Rodríguez, Andrés|||0000-0001-7018-0711
  • Modrego, Javier|||0000-0002-2200-9503
  • Ortega-Hernández, Adriana
  • Marcos-Alberca, Pedro
  • Magni, Ricardo
  • Calvo, Enrique
  • Gómez-Gordo, Rubén
  • Yan, Ping
  • La Rosa, Giulio
  • Bustamante-Madrión, José
  • Pérez-García, Carlos Nicolás|||0000-0001-8875-9633
  • Martín-Sánchez, Francisco Javier|||0000-0002-5970-725X
  • Calvo, David
  • de la Hera, Jesús M.
  • García-Torrent, María Jesús|||0000-0001-5264-608X
  • García Osuna, Álvaro|||0000-0002-6682-0226
  • Ordóñez, J. (Jordi)|||0000-0003-4896-5832
  • Vázquez, Jesús|||0000-0003-1461-5092
  • Pérez-Villacastín, Julián|||0000-0002-4867-3912
  • Pérez-Castellano, Nicasio
  • Loew, Leslie M.
  • Sánchez González, Javier|||0000-0003-1427-3870
  • Gómez-Garre, Dulcenombre|||0000-0002-5056-6489
  • Filgueiras-Rama, David|||0000-0001-5909-2454
Electromechanical characterization during atrial fibrillation (AF) remains a significant gap in the understanding of AF-related atrial myopathy. This study reports mechanistic insights into the electromechanical remodeling process associated with AF progression and further demonstrates its prognostic value in the clinic. In pigs, sequential electromechanical assessment during AF progression shows a progressive decrease in mechanical activity and early dissociation from its electrical counterpart. Atrial tissue samples from animals with AF reveal an abnormal increase in cardiomyocytes death and alterations in calcium handling proteins. High-throughput quantitative proteomics and immunoblotting analyses at different stages of AF progression identify downregulation of contractile proteins and progressive increase in atrial fibrosis. Moreover, advanced optical mapping techniques, applied to whole heart preparations during AF, demonstrate that AF-related remodeling decreases the frequency threshold for dissociation between transmembrane voltage signals and intracellular calcium transients compared to healthy controls. Single cell simulations of human atrial cardiomyocytes also confirm the experimental results. In patients, non-invasive assessment of the atrial electromechanical relationship further demonstrate that atrial electromechanical dissociation is an early prognostic indicator for acute and long-term rhythm control. Electromechanical characterization during atrial fibrillation (AF) remains a significant gap in the understanding of AF-related atrial myopathy. Here, the authors use non-invasive atrial electromechanical assessment during AF to identify early remodeling changes associated with underlying myopathy, which in the clinic decrease the probability of acute and mid-term successful rhythm control.